Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT)
B.G. Haffty,S. Goyal,C. Green,D. Schiff,Q. Yang,M.S. Moran,D. Kulkarni,S. Ganesan,K. Hirshfield
DOI: https://doi.org/10.1016/j.ijrobp.2009.07.040
IF: 8.013
2009-01-01
International Journal of Radiation Oncology*Biology*Physics
Abstract:Single nucleotide polymorphisms (SNPs) are common germ line genetic changes that are present in all cells, including tumor, stroma, and normal tissue of an individual. The TP53BP1 was initially isolated as a p53 interacting protein, and has been shown to be a key component of radiation-induced DNA damage repair; 53BP1-deficient mice are radiation sensitive and TP53BP1 has been shown to be a positive regulator of the promoter of BRCA1. Given its critical role in DNA repair and the fact that several common SNPs have been identified in the protein coding portion of the gene, TP53BP1 is an attractive candidate gene to evaluate for RT outcomes. The purpose of this study was to evaluate the significance of an identified common SNP in this gene identified as D353E:1059C>G (rs560191) in a cohort of premenopausal patients treated with BCS+RT. The patient population consisted of 176 premenopausal women treated with standard BCS+RT and appropriate systemic therapy with a median follow-up of 12 years from diagnosis. Genomic DNA was processed using TaqMan allelic discrimination assays; each allele for the rs560191 locus was either C or G. Genotyping for each patient was thus categorized as CC, CG, or GG; patients were classified as CC-TYPE if they were homozygous for the ancestral C allele (CC) or G-TYPE if they carried at least one copy of the nonancestral G allele (GG or CG). All clinical, pathologic, treatment, and outcomes data, along with the results of the SNP analysis, were entered into a computerized database, de-identified, and analyzed with standard statistical packages. Of the 176 premenopausal women, 124 (71%) were classified as G-TYPE and 52 (29%) as CC-TYPE. The mean age was 44 years for the CC-TYPE vs. 38 years for the G-TYPE (p < 0.001) and CC-TYPE was more common in African Americans compared to white women (71% vs. 14%; p < 0.001). There were no significant correlations of rs560191 with other critical variables: T-Stage, N-Stage, margin status, use of adjuvant therapy, or family history. Despite the fact that CC-TYPE were older, the 10-year rate of local relapses was higher (22% CC-TYPE vs. 12% G-TYPE, p = 0.04). The rate of contralateral events in CC-TYPE was slightly, but not significantly higher at 10 years (13% vs. 8%; p = NS). This novel avenue of investigation of polymorphisms in radiation repair and response genes in patients who have undergone BCS+RT suggest that there may be a correlation to local relapse in patients homozygous for the ancestral C allele. Additional basic science evaluation is needed to assess the biologic and functional significance of these SNPs and larger confirmatory validation studies will be required to determine the clinical implications.